hydrochlorothiazide has been researched along with 20-hydroxy-5,8,11,14-eicosatetraenoic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, C; Cheng, J; Lin, F; Ma, F; Wang, DW; Wang, Y; Zeldin, DC | 1 |
| Capdevila, JH; Falck, JR; Gangadhariah, MH; Garcia, V; Hayward, SW; Imig, JD; Love, HD; Luther, JM; Manthati, VL; Paueksakon, P; Pozzi, A; Schwartzman, ML; Zent, R; Zhang, MZ | 1 |
2 other study(ies) available for hydrochlorothiazide and 20-hydroxy-5,8,11,14-eicosatetraenoic acid
| Article | Year |
|---|---|
Indapamide lowers blood pressure by increasing production of epoxyeicosatrienoic acids in the kidney.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Cytochrome P-450 CYP2J2; Cytochrome P-450 Enzyme System; Epoxide Hydrolases; Hydrochlorothiazide; Hydroxyeicosatetraenoic Acids; Indapamide; Inflammation; Kidney; Male; Mitogen-Activated Protein Kinase 1; NADPH Oxidases; NF-kappa B; Oxidative Stress; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Sodium Chloride Symporter Inhibitors; Transforming Growth Factor beta1 | 2013 |
Hypertension is a major contributor to 20-hydroxyeicosatetraenoic acid-mediated kidney injury in diabetic nephropathy.
Topics: Animals; Collagen; Cytochrome P-450 Enzyme System; Cytochrome P450 Family 4; Diabetic Nephropathies; Glomerular Basement Membrane; Hydralazine; Hydrochlorothiazide; Hydroxyeicosatetraenoic Acids; Hypertension; Male; Mice, Knockout; Orchiectomy; Renin-Angiotensin System; Reserpine; Sodium | 2015 |